Duchenne Muscular Dystrophy (DMD): A Parent's Guide to Symptoms, Causes and Care

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 17, 2026

Quick Answer

Duchenne muscular dystrophy is a progressive genetic condition causing skeletal and heart muscle weakness that worsens over time [1]. Symptoms usually begin by age 6, most often between ages 2 and 4, and mainly affect boys [1]. It is caused by a missing or faulty dystrophin gene [1]. There is no cure, but steroids, gene-based therapy and supportive care slow progression [1].

What the research says

• DMD is rare, and published estimates vary widely. A systematic review of 44 studies (40 pooled in the meta-analysis) estimated a pooled global prevalence of 7.1 cases per 100,000 males and a pooled birth prevalence of 19.8 per 100,000 live male births. Between-study heterogeneity was very high (I² > 90%) and none of the studies were rated high quality, so any single figure should be read as an approximation (PubMed: Crisafulli et al., Orphanet J Rare Dis, 2020 [3]).

• Survival has improved substantially, and breathing and heart care are central. A meta-analysis of 53 studies covering more than 13,000 patients found median survival of 29 years in patients on home mechanical ventilation versus 19 years in those without it. Glucocorticoid therapy was not associated with longer survival (p = 0.45), while heart failure medications, including renin-angiotensin system inhibitors (p = 0.002) and β-blockers (p = 0.02), were; the leading causes of death shifted from respiratory to cardiac (PubMed: Benning et al., J Neurol, 2026 [2]).

• Vamorolone, a steroid alternative, showed benefit with fewer side effects in early studies. A systematic review of 6 studies (145 boys, baseline age 4.7–5.5 years) found that the most effective dose, 6 mg/kg/day, improved the 6-minute walk test by 41.60 m (95% CI 14.30–68.90) at 24 weeks compared with untreated cohorts, with fewer adverse events than historical cohorts treated with glucocorticoids. The authors note the small number of studies limits conclusions (PubMed: Pascual-Morena et al., Paediatr Drugs, 2024 [4]).

What Is Duchenne Muscular Dystrophy?

Duchenne muscular dystrophy (DMD) is a progressive condition that causes muscles to get weaker over time. It mainly affects the muscles used for movement, breathing and heart function [1].

DMD is inherited and typically affects males. Symptoms usually start in early childhood and slowly get worse. As a child grows, you might notice developmental delays, toe walking or muscle weakness [1].

Quick fact	Detail
What it is	A progressive condition causing muscles to weaken over time, affecting movement, breathing and heart muscles
Who it affects	Mainly boys — about 1 in every 3,600 male infants [1]
How common	The most common form of muscular dystrophy and the leading type of severe inherited muscle disorder [1]
When symptoms start	Usually between ages 2 and 4; typically begin by age 6
What causes it	A genetic variant that leaves the body with little or no dystrophin protein
Is there a cure?	Not currently — but treatments can slow progression and manage symptoms
Life expectancy	Typically into early adulthood, though it varies; advances have helped many live longer

Figure 1: Duchenne muscular dystrophy — how it weakens muscles, how common it is, and why it mainly affects boys.

Signs and Symptoms of DMD

Symptoms may start during infancy but become more noticeable during early childhood. They worsen over time and may include muscle weakness, stiff joints, developmental delay (like saying their first words and sitting up), fatigue and loss of muscle bulk [1].

Muscle weakness can affect how your child walks and moves. You might notice these signs:

Walking and movement signs	General symptoms
Difficulty climbing stairs, running or jumping	Muscle weakness
Frequent falls	Stiff joints
Increase in calf muscle size	Developmental delay (first words, sitting up)
Toe walking	Fatigue
Using arms to push themselves up from the ground	Loss of muscle bulk
Waddling	—

Timing matters: symptoms usually appear between the ages of 2 and 4 [1]. They can start as early as infancy, but you might not notice them until later in childhood. If you see several of these signs together — especially toe walking, frequent falls and enlarged calves — it's worth raising them with your child's pediatrician.

Figure 2: Early signs of DMD parents often notice between ages 2 and 4.

What Causes Duchenne Muscular Dystrophy?

A genetic variant causes DMD. This gene tells the body how to make a protein called dystrophin, which keeps muscles strong and protects them when they move [1].

If your child has this condition, their body makes little or no dystrophin. Without it, muscles become weak and start to break down. Over time, muscle cells die and the body can't replace them. Instead, the empty spaces fill with fat and scar tissue — which makes movement even harder [1].

Step	What happens in DMD
1	Genetic variant disrupts the dystrophin gene
2	Body makes little or no dystrophin protein
3	Muscles become weak and start to break down
4	Muscle cells die and can't be replaced
5	Fat and scar tissue fill the empty spaces
6	Movement becomes harder as damage progresses

How DMD Is Inherited

DMD is usually passed down through families. It's X-linked recessive, which shapes who it affects and why.

The gene that causes DMD sits on the X chromosome, one of the two sex chromosomes. Boys have one X and one Y chromosome (the X comes from mom, the Y from dad). Girls have two X chromosomes (one from each parent).

Because boys only have one X chromosome, if that X carries the gene change that causes DMD, they'll have the disease — there's no backup copy on another X chromosome to make up for it [1]. Girls, on the other hand, have a backup copy on their other X chromosome and typically won't be affected [1].

Child's chromosomes	Risk of DMD
Boy with the changed X	Will have the disease — no backup X copy
Girl with one changed X	Typically won't be affected — backup copy protects; may become a carrier
Carrier girl (no symptoms or very mild)	May pass the gene change to her future children

Girls either don't have symptoms or their symptoms are very mild. Girls may become carriers — they inherit the gene change but don't have symptoms, and may pass the gene on to their future children [1].

However, in about 3 out of 10 cases, the gene change happens randomly [1]. This means it wasn't passed down and there wasn't a family history. There's no way to prevent Duchenne muscular dystrophy [1].

How Is DMD Diagnosed?

If your child shows signs, see their pediatrician. Their provider will do a physical, neurological and muscle exam, and will also ask about your child's symptoms and medical history [1].

If they suspect DMD, your provider may refer you to a pediatric neurologist or order these tests to confirm a diagnosis:

Test	What it checks
Creatine kinase (CK) blood test	High CK levels suggest muscle damage — in DMD, levels can be 10 to 20 times above normal by age 2 [1]
Genetic test	Confirms the condition by checking for missing or faulty dystrophin genes
Muscle biopsy	A small muscle sample (usually from the thigh or calf) helps the provider look for DMD-related changes
Electrocardiogram (EKG)	Checks heart function, as the disease often affects the heart

Figure 3: Diagnosing and managing DMD — the pediatric exam, confirming tests, and coordinated care.

How Is Duchenne Muscular Dystrophy Treated?

There's currently no cure for DMD. The main goal of treatment is to manage symptoms and slow progression [1]. A range of supportive therapies may be used, often in combination.

Treatment type	What it does
Steroid medications	Prednisone or deflazacort may slow muscle damage and help maintain strength [1] and independent movement, breathing and heart function
Steroid alternatives	Vamorolone fights inflammation in muscles and heart cells, helping protect them and maintain mobility and strength longer [1]
Gene-based therapy	Medications like eteplirsen, delandistrogene, golodirsen, casimersen and viltolarsen help the body produce a shorter but functional form of dystrophin [1]; some work only for certain variant types
HDAC inhibitor	Givinostat turns on genes that repair and grow muscles and reduce fibrosis (scar tissue), which may slow muscle function decline [1]
Heart care	ACE inhibitors or beta-blockers may protect the heart [1] [2]; regular check-ups and heart imaging usually begin around age 6 [1]
Physical therapy	Stretching and exercises prevent joint and muscle issues; therapists may recommend braces, splints or mobility aids
Nutrition	Calcium and vitamin D supplements support bone health; a nutritionist can help ensure balanced meals throughout the day
Exercise	Light activities like swimming or supervised play keep muscles active; your provider can guide what's safe
Breathing support	Devices like a BiPAP or ventilator may help over time with breathing, especially during sleep [1]

To learn how therapists help restore and protect movement, read our guide to physical therapy.

When Should Your Child See Their Provider?

If your child has this condition, they'll need regular visits with their care team to manage treatment and track symptoms. You'll get to know their providers well, as ongoing care is essential. As your child grows and their symptoms change, their treatment plan may need to adjust, too [1].

Care milestone	What to expect
Around diagnosis	Confirm through CK, genetics, biopsy and EKG; assemble the care team
Ongoing	Regular visits to track symptoms and adjust the treatment plan
Around age 6	Regular heart check-ups and imaging usually begin
As symptoms change	Treatment plan adjusts — mobility aids, breathing support or other therapies added over time

Outlook: What to Expect Over Time

This disease is progressive despite treatment — it gets worse over time. The outlook is poor, as it shortens lifespan [1]. That's a hard truth, and it deserves to be named honestly.

You can expect that your child will need to use a wheelchair by their 12th birthday [1]. But this loss of mobility shouldn't take away from their ability to play and enjoy childhood moments.

Life expectancy: people with DMD typically live into early adulthood, though it varies. Advances in treatment and supportive care have helped many live longer than once expected [1] [2].

Prognosis factor	What to expect
Disease course	Progressive despite treatment — worsens over time
Mobility	Wheelchair use typically needed by the 12th birthday
Life expectancy	Typically into early adulthood; varies; advances have helped many live longer
Main complications	Heart or breathing complications; sometimes pneumonia or airway blockages become serious

A Note for Parents

Learning that your child has DMD is incredibly difficult. It's a life-changing diagnosis, and it's OK to feel overwhelmed.

While DMD will bring challenges, it doesn't take away their ability to be a kid. They can still splash in the pool, play with friends and tell silly jokes. They'll grow, learn and find their own way to thrive — and you'll be right beside them.

As you care for your child, remember to care for yourself, too. Talking with a mental health professional or connecting with others through a support group can make a difference [1]. If you have any questions about your child's condition or how to get support for yourself, talk to a provider.

Key Takeaways

Duchenne muscular dystrophy is a life-changing diagnosis — one that no family is prepared for. But “no cure yet” is not the same as “nothing can be done.” Today's care combines steroids, gene-based therapies, heart and breathing support, physical therapy and nutrition into a coordinated plan that slows progression and protects a child's strength for as long as possible. The milestones ahead — the wheelchair by age 12, the heart monitoring from around age 6, the breathing support that may come later — are real, and naming them is part of good care. So is protecting childhood: swimming, playing with friends and telling silly jokes are all still on the table.

Take the Next Step

If your child is showing several of the early signs — toe walking, frequent falls, enlarged calves, waddling, or delays in first words and sitting up — bring them up with their pediatrician. A simple creatine kinase blood test is often the first step, and the earlier DMD is identified, the sooner a coordinated care plan can begin.

Related reading: physical therapy

Further reading: Muscular Dystrophy Association — Duchenne Muscular Dystrophy, Genetic and Rare Diseases Information Center — Duchenne Muscular Dystrophy, MedlinePlus — Duchenne muscular dystrophy

Frequently Asked Questions

1. What is Duchenne muscular dystrophy?

Duchenne muscular dystrophy (DMD) is a progressive genetic condition that causes muscles to get weaker over time, mainly affecting the muscles used for movement, breathing and heart function. It typically affects males, starts in early childhood and slowly gets worse.

2. How common is Duchenne muscular dystrophy?

DMD affects about 1 in every 3,600 male infants. It is the most common form of muscular dystrophy and the leading type of severe inherited muscle disorder (myopathy).

3. What are the early signs of DMD?

Early signs usually appear between ages 2 and 4 and include muscle weakness, stiff joints, fatigue, loss of muscle bulk and developmental delays such as late first words or sitting up. Walking changes are common: difficulty climbing stairs, running or jumping, frequent falls, enlarged calf muscles, toe walking, waddling and using the arms to push up from the ground.

4. What causes Duchenne muscular dystrophy?

A genetic variant disrupts the gene that tells the body how to make dystrophin, the protein that keeps muscles strong and protects them during movement. Without dystrophin, muscles break down, muscle cells die and can't be replaced, and the empty spaces fill with fat and scar tissue.

5. Why does DMD mainly affect boys?

DMD is X-linked recessive, meaning the gene change sits on the X chromosome. Boys have only one X chromosome, so a changed gene causes the disease with no backup copy. Girls have two X chromosomes and a backup copy, so they typically aren't affected — though they can become carriers who pass the gene on.

6. Is DMD always inherited?

No. In about 3 out of 10 cases, the gene change happens randomly, meaning it wasn't passed down and there was no family history. Either way, there is no way to prevent DMD.

7. How is DMD diagnosed?

A pediatrician starts with a physical, neurological and muscle exam. Confirming tests include a creatine kinase (CK) blood test (levels can be 10 to 20 times normal by age 2), a genetic test for missing or faulty dystrophin genes, a muscle biopsy (usually from the thigh or calf) and an EKG to check heart function.

8. How is Duchenne muscular dystrophy treated?

There is no cure, so treatment focuses on managing symptoms and slowing progression. Options include steroid medications (prednisone, deflazacort), the steroid alternative vamorolone, gene-based therapies (eteplirsen, delandistrogene, golodirsen, casimersen, viltolarsen), the HDAC inhibitor givinostat, heart medications, physical therapy, nutrition support, light exercise and breathing support devices like BiPAP or a ventilator.

9. What is the life expectancy with DMD?

People with DMD typically live into early adulthood, though life expectancy varies. Advances in treatment and supportive care have helped many live longer than once expected. Most face complications related to their heart or breathing.

10. Will my child need a wheelchair?

Yes, in most cases you can expect a child with DMD to need a wheelchair by their 12th birthday. But this loss of mobility shouldn't take away from their ability to play and enjoy childhood moments.

11. How can I support myself as a parent of a child with DMD?

It's a life-changing diagnosis and it's OK to feel overwhelmed. Talking with a mental health professional, connecting with a support group and asking your provider for resources can make a difference. Your child can still splash in the pool, play with friends and thrive — and caring for yourself helps you stay right beside them.

Related Reading

Learn more in our guide to Creatine Kinase (CK) Test: What It Is, Normal Levels and High CK Causes.

References

1. Cleveland Clinic. Duchenne Muscular Dystrophy (DMD). Cleveland Clinic. June 27, 2025. https://my.clevelandclinic.org/health/diseases/23538-duchenne-muscular-dystrophy-dmd

2. Benning L, Bousraou Z, Gruber B, Ulrich S, Schwarz EI. Improving survival in Duchenne muscular dystrophy across eras: a systematic review and cumulative meta-analysis. J Neurol. 2026;273(10):564. doi:10.1007/s00415-026-14121-4. PMID: 42701154.

3. Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifirò G. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis. 2020;15(1):141. doi:10.1186/s13023-020-01430-8. PMID: 32503598.

4. Pascual-Morena C, Lucerón-Lucas-Torres M, Martínez-García I, Rodríguez-Gutiérrez E, Patiño-Cardona S, Sequí-Domínguez I. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: a systematic review. Paediatr Drugs. 2024;26(6):695-707. doi:10.1007/s40272-024-00655-5. PMID: 39331339.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here.